Glaucoma Surgery Market Analysis

Global Glaucoma Surgery Market Overview

Glaucoma Surgery Market Size was valued at USD 0.6 billion in 2022 and is projected to grow from USD 0.63 Billion in 2023 to USD 1.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.7% during the forecast period (2024 - 2032). Increasing the number of patients and improving healthcare facilities are the key market drivers for enhancing market growth. 

  Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Glaucoma Surgery Market Trends

• Growing Prevalence of surgeries to boost market growth

Glaucoma surgeries have increased globally to address the backlog of surgical operations brought on by the pandemic restrictions. This has offset the market growth during the later stages of the epidemic. The market is expanding due to the increased awareness of glaucoma treatment and prevention in recent years. For instance, the newly created Dr. B. R. Ambedkar State Institute of Medical Sciences, Mohali, organized the first Glaucoma Awareness Walk in March 2022 to raise awareness of the disease's potential causes and treatment alternatives. According to the awareness campaign, approximately 40 million individuals in India, or one out of every eight people, have glaucoma or are at risk of getting it. Of the 11.2 million Indians with the disease, 1.1 million are blind, including children. As a result, it is projected that the high prevalence of the disease will increase demand for glaucoma surgery equipment in the coming years.

Moreover, the study market's expansion is being actively impacted by the rising glaucoma prevalence, the growing geriatric population, and the expanding use of surgical therapies for glaucoma.

The World Glaucoma Association (WGA) anticipated that 79.6 million individuals would have glaucoma worldwide in 2020 in its 2022 update. By 2040, there will likely be 111.8 million individuals living with glaucoma, according to predictions. Also, it was noted that at least 50% of glaucoma sufferers are ignorant of their illness. In certain impoverished nations, 90% of glaucoma patients go undiagnosed. As a result, the rise in glaucoma is linked to the rise in glaucoma surgery, which is expected to drive the market for glaucoma surgical equipment ultimately. Therefore, such condition related has enhanced the Glaucoma Surgery market CAGR across the globe in the recent years.

However, increase the demand for surgery devices is another factor driving the growth of the Glaucoma Surgery market revenue.

Glaucoma Surgery Market Segment Insights

Glaucoma Surgery Target Insights

Based on target, the Glaucoma Surgery Market segmentation includes trabecular meshwork, suprachoroidal space, and others. The trabecular meshwork segment held the majority share in 2022, contributing to around ~38% of the Glaucoma Surgery Market revenue. Increased intraocular pressure is the primary risk factor for glaucoma, an optic neuropathy that causes blindness (IOP). The primary route for aqueous humor (AH) draining out of the eye is the trabecular meshwork, which is situated within the iridocorneal angle; malfunction of this structure causes the IOP to rise.

Glaucoma Surgery Type of surgery Insights

The Glaucoma Surgery Market segmentation, based on the Type of surgery, includes Angle-closure glaucoma surgery, aqueous shunt surgery, laser surgery, and others. The Angle-closure glaucoma surgery segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period 2024-2032. The need for alternatives is being driven by causes such as more extended hospital stays, the availability of various cutting-edge surgical techniques and devices, and the likelihood of postoperative problems such as leakage, hypotony, choroidal effusion, and hyphema increasing. Yet, conventional surgery is still the treatment of choice in underdeveloped nations where private actors dominate the healthcare services sector. According to the NCBI analysis, a subconjunctival space implant costs around 3.5 times as much as a trabeculectomy. Hence, rising applications of Angle-closure glaucoma surgery material implants for Glaucoma Surgery positively impact the market growth.

Figure 1: Glaucoma Surgery Market, by Type of Surgery, 2022 & 2030 (USD billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Glaucoma Surgery End User Insights

Based on End Users, the global Glaucoma Surgery industry has been segmented into Hospitals, ambulatory surgery centers, and others. The hospital held the most significant segment share in 2022; the main drivers anticipated to drive the segment's growth include the segment's large patient base, the availability of highly experienced medical professionals, and advanced surgical devices.

The fastest-growing segment in the Glaucoma Surgery industry is ambulatory surgery centers. Increased investments in glaucoma research, an increase in undetected cases, and inadequate healthcare infrastructure in rural areas are just a few of the variables anticipated to drive sector expansion throughout the projected period.

Glaucoma Surgery Regional Insights

The analysis offers market insights for North America, Europe, Asia-Pacific, and the rest of the world, organized by region. In 2022, the North American Glaucoma Surgery market had a value of USD 0.27 billion, and throughout the research period, it is anticipated to rise at a high CAGR. Due to factors such as the increasing prevalence of glaucoma, the aging population, improved healthcare infrastructure, public awareness of accessible technologies among healthcare stakeholders, and the region's significant concentration of industry participants. According to the World Glaucoma Association's (WGA) 2022 report, glaucoma-related blindness would rank third among medical conditions Americans fear most in 2022, after cancer and heart attacks. Consequently, it is predicted that the fear of glaucoma and its rising incidence in the nation would increase demand for glaucoma surgical operations, increasing market growth in the area.

Further, the significant countries studied in the market report are The U.S., Germany,  Canada, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: GLAUCOMA SURGERY MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Glaucoma Surgery market accounts for the second-largest market share. There is a dynamic reimbursement paradigm in the region for glaucoma surgery, with certain nations having adequate coverage for new surgical instruments and techniques. In contrast, others are forced to provide trabeculectomy services despite more options. Further, the Germany Glaucoma Surgery market held the largest market share, and the UK Glaucoma Surgery market was the fastest-growing market in the European region.

The Asia-Pacific Glaucoma Surgery Market is expected to grow at the fastest CAGR. High unmet demands and rising rates of open-angle glaucoma, particularly in nations like Japan, China, and India, are anticipated to drive the market's expansion in this area. Strong demand for MIGS devices is also anticipated in the region due to the ongoing development of its healthcare infrastructure. Moreover, the China Glaucoma Surgery market held the largest market share, and the India Glaucoma Surgery market was the fastest-growing market in the Asia-Pacific region.

Glaucoma Surgery Key Market Players & Competitive Insights

Prominent market companies are investing a lot of money in R&D to expand their product portfolios, which will spur further market growth for glaucoma surgery. With significant market developments like new product releases, contractual arrangements, acquisitions and mergers, increased investments, and partnerships with other organizations, market participants are also undertaking various strategic activities to expand their global presence. To grow and survive in an environment where fierce competition exists, and market demand is rising, competitors in the glaucoma surgery business must provide affordable products.

Industrial production locally to cut operating costs is one of the primary business tactics used by manufacturers in the worldwide Glaucoma Surgery business to benefit customers and expand the marketplace. Some of medicine's most important recent advances have come from the glaucoma surgery business. Major players in the glaucoma surgery industry, including Alcon, and others, are attempting to increase market demand by funding R&D initiatives.

With its headquarters in Geneva, Switzerland, and its incorporation in Fribourg, Switzerland, Alcon is an American Swiss medical firm specializing in eye care products. The Alcon part of the corporation was founded in Fort Worth, Texas, where Alcon was first established as a US company. In April 2021, Ivantis, Inc. sold the Hydrus Microstent for Surgical Glaucoma to Alcon. The projected acquisition expanded the company's already extensive line of treatments for glaucoma, cataracts, and retinal illnesses, demonstrating Alcon's commitment to the market.

Also, American pharmaceutical business AbbVie Inc. was established in 2013. One of the biggest pharmaceutical firms in the world, it was founded as a spin-off of Abbott Laboratories, and it frequently ranks in the top three worldwide in terms of revenue.In May 2020, AbbVie Inc. purchased Allergan plc, a company focused on developing, manufacturing, and marketing branded pharmaceutical products globally in pharmaceutical, biological, surgical, and regenerative medicine.

Key Companies in the Glaucoma Surgery market includes

• Abbott Laboratories Inc


• Carl Zeiss Meditec.


• Ziemer Ophthalmic Systems


• ASICO, LLC.


• Lumenis


• Allergan


• Alcon


• Katalyst Surgical LLC


• Glaukos Corporation among others

Glaucoma Surgery Industry Developments

November 2023:Glaukos Corporation announces that the FDA has approved its iStent inject Trabecular Micro-Bypass System for the treatment of open-angle glaucoma (OAG). The iStent inject is a minimally invasive glaucoma surgery (MIGS) device that is implanted in the trabecular meshwork of the eye to improve drainage and reduce intraocular pressure (IOP). 

October 2023:Johnson & Johnson Vision announces that it has received CE Mark approval for its Xact Robotic System for Glaucoma Surgery. The Xact Robotic System is a robotic-assisted surgical platform that is designed to provide surgeons with greater precision and control during MIGS procedures. 

September 2023:Alcon announces that it has launched its new Hydrus Microstent in the United States. The Hydrus Microstent is a MIGS device that is designed to reduce IOP by creating a new bypass channel for aqueous humor to drain from the eye. 

August 2023:Bausch + Lomb announces that it has received FDA approval for its enVista Aspire intermediate-optimized monofocal and toric intraocular lenses (IOLs). The enVista Aspire IOLs are designed to provide patients with clear vision at all distances after cataract surgery and glaucoma surgery.

July 2023:Nova Eye Medical, Inc. announces that it has received FDA clearance for its iClear Microstent. The iClear Microstent is a MIGS device that is designed to reduce IOP by creating a new bypass channel for aqueous humor to drain from the eye.

Glaucoma Surgery Market Segmentation

Glaucoma Surgery Target Outlook

• Trabecular meshwork


• Suprachoroidal space

Glaucoma Surgery Type of surgery Outlook

• Angle closure glaucoma surgery


• Aqueous shunt surgery


• laser surgery


• Others

Glaucoma Surgery End User Outlook

• Hospital


• Ambulatory surgery centers


• Others

Glaucoma Surgery Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America